Jingtian & Gongcheng advised Hygeia Health on the oncology company’s RMB1.66 billion (USD231.63 million) 100% acquisition of Chang An Hospital.
The Jingtian team advised the H-Share company on PRC law in the transaction where Hygeia purchased the shares from Datang Healthcare (Hong Kong) and Chang An, which is a tertiary general hospital famous for its cancer department, ranking 13th out of the top 100 social-run hospitals by Asclepius Hospital Management in 2022.
